Last reviewed · How we verify
NCT05070507
Effect of an Enzyme-containing Lozenge on Dental Biofilm in Healthy Individuals.
NA trial testing Enzyme containing lozenge in Dental Plaque in 24 participants. Completed in 10 May 2021.
26 February 2021
Quick facts
| Lead sponsor | Novozymes A/S |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 24 |
| Start date | 8 January 2021 |
| Primary completion | 26 February 2021 |
| Estimated completion | 10 May 2021 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Enzyme containing lozenge
- Placebo lozenge — full drug profile →
Conditions studied
- Dental Plaque — all drugs for Dental Plaque →
- Gingivitis — all drugs for Gingivitis →
- Microbial Colonization — all drugs for Microbial Colonization →
Sponsor
Novozymes A/S
Who can join
18 and older, any sex, with Dental Plaque or Gingivitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to assess the effect of an enzyme containing lozenge on dental plaque accumulation in healthy adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05070507
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Enzyme containing lozenge
Trials testing the same drug.
- NCT06142409 — Effect of Enzyme-containing Lozenge on Dental Biofilm Formation, Composition and Functionality · NA · completed
Other recruiting trials for Dental Plaque
Currently open trials in the same condition.
- NCT07088666 — 0.2% Chlorhexidine vs MicroRepair ABX in Gingivitis · NA · recruiting
- NCT07356869 — Probiotic-Based Versus Ethyl Lauroyl Arginate-Containing Mouthwashes on Streptococcus Mutans Counts, Dental Plaque Accum · NA · recruiting
- NCT07119840 — Comparison Of Clinical Effects Of Listerine And Chlorhexidine Mouth Wash In Patients Undergoing Fixed Orthodontic Treatm · NA · recruiting
- NCT07115784 — Clinical Efficacy of Chlorhexidine Varnish in Reducing Gingival Hyperplasia, Plaque Accumulation, and White Spot Lesions · NA · recruiting
- NCT07029360 — Effectiveness of Coenzyme Q10 and Probiotics in Periodontal Therapy During Pregnancy · NA · recruiting
Other Novozymes A/S trials
Trials by the same sponsor.
- NCT07163637 — Effect of Limosilactobacillus Reuteri DSM 17648 in Healthy Adults Reporting Upper Gastrointestinal Discomfort · NA · recruiting
- NCT06107088 — Effect of a Combination of Lactase and L. Salivarius DSM 34078 in Individuals With Lactose Intolerance · NA · completed
- NCT07079683 — RCT: Enzyme Blend Toothpaste on Dental Biofilm Plaque Accumulation · NA · completed
- NCT06142409 — Effect of Enzyme-containing Lozenge on Dental Biofilm Formation, Composition and Functionality · NA · completed
- NCT05507021 — Effect of Lactobacillus Plantarum DSM 33464 on Blood Lead Levels in Young Women of Child-bearing Age · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05070507 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Novozymes A/S
- Last refreshed: 7 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05070507.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing